NCT01988350

Brief Summary

Pancreatic insufficiency is a condition in which there is a decrease in the production and release of enzymes made in the pancreas, which causes nutrient malabsorption. There are many chronic diseases that can lead to pancreatic insufficiency. In the early stages of this disease, a patient may not experience any symptoms, and the prevalence of pancreatic insufficiency may be underestimated. Smoking has long been recognized as a cause of disease in many organs in the body. Cigarette smoke causes inflammation and damages tissue, including the pancreas. Studies have shown that smoking is an independent risk factor for pancreatic cancer and chronic pancreatitis. It has also been shown that the more a person smokes, the worse his disease will be. Additionally, there are studies that show that smokers have nutritional deficiencies. There are observational and retrospective studies that suggest that pancreatic insufficiency may also be caused by smoking. However, this has not been established, and the relationship has not been examined in a controlled manner. This study examines the relationship between smoking and pancreatic insufficiency in patients who do not have other pancreatic diseases.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
202

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 24, 2013

Completed
8 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 20, 2013

Completed
Last Updated

November 20, 2013

Status Verified

November 1, 2013

Enrollment Period

3 months

First QC Date

July 24, 2013

Last Update Submit

November 13, 2013

Conditions

Keywords

pancreatic insufficiencypancreatic elastasefecal elastasesmokingtobacco

Outcome Measures

Primary Outcomes (1)

  • pancreatic insufficency

    The primary outcome is presence or absence of pancreatic insufficiency as determined by fecal elastase-1 measurement

    1-2 weeks after provision of stool specimen

Study Arms (2)

Non-smokers

Smokers

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Smokers and non-smoking controls without a h/o pancreatic disease.

You may qualify if:

  • Male or female at least 30 years of age
  • Able to read, understand, and sign informed consent
  • Patients with a negligible smoking history (defined as no smoking for the past 7 years, and a total smoking history ≤ 5 pack-years) OR patients with AT LEAST a 20 pack-year smoking history

You may not qualify if:

  • Patients with a prior diagnosis of pancreatic insufficiency
  • Patients who have a current or remote history of acute or chronic pancreatitis or any other primary pancreatic disease or malignancy
  • Patients who have had pancreatic surgery
  • Patients with a diagnosis of small bowel malabsorption or Celiac disease
  • Patients with any other significant systemic disease that is deemed by the investigator as possibly interfering with the conduct or interpretation of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Emory Clinic

Atlanta, Georgia, 30322, United States

Location

Related Publications (1)

  • Raphael KL, Chawla S, Kim S, Keith CG, Propp DR, Chen ZN, Woods KE, Keilin SA, Cai Q, Willingham FF. Pancreatic Insufficiency Secondary to Tobacco Exposure: A Controlled Cross-Sectional Evaluation. Pancreas. 2017 Feb;46(2):237-243. doi: 10.1097/MPA.0000000000000721.

MeSH Terms

Conditions

Exocrine Pancreatic InsufficiencySmoking

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesBehavior

Study Officials

  • Field F Willingham, MD, MPH

    Emory University School of Medicine, Division of Gastroenterology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Endoscopy

Study Record Dates

First Submitted

July 24, 2013

First Posted

November 20, 2013

Study Start

May 1, 2013

Primary Completion

August 1, 2013

Study Completion

August 1, 2013

Last Updated

November 20, 2013

Record last verified: 2013-11

Locations